Timothy Churchill

Massachusetts General Hospital
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Disorders of the pulmonic valve (PV) receive considerably less attention than other forms of valvular heart disease. Due to the dramatically improved survival of children with congenital heart disease over the last 5 decades, there has been a steady increase in the prevalence of adults with congenital heart disease, which necessitates that clinicians become familiar with the anatomy and the evaluation of right ventricular outflow tract and PV anomalies. A multimodality imaging approach using echocardiography, cardiac computed tomography, and magnetic resonance imaging is essential for a comprehensive evaluation of the anatomy and function of the right ventricular outflow tract, PV, and supravalvular region. As clinical presentation is often insidious with nonspecific symptoms, yet morbidity and mortality associated with severe untreated PV disease are significant, a high index of suspicion coupled with appropriate use of imaging techniques is critical in facilitating timely diagnosis and treatment. In this review, we aim to present a comprehensive approach to the diagnosis of PV disease and associated right ventricular outflow tract or supravalvular pulmonary stenosis, including optimal use of multimodality imaging to facilitate timely diagnosis, optimize therapeutic strategies, enhance postprocedural surveillance, and ultimately improve patient outcomes.

Year:

2025

The athlete’s heart, formally introduced by Henschen and Darling in 1899 through observations of cardiac enlargement in endurance athletes, has evolved from a clinical curiosity to a recognized physiological adaptation. Even before this naming, similar constructs such as the soldier’s heart in military recruits and the runner’s heart in distance athletes suggested early observations of exercise-associated cardiac remodeling—often pathologized or mischaracterized. Today, this phenomenon is understood as exercise-induced cardiac remodeling, comprising structural, functional, and electrical changes that support the demands of sustained athletic performance. This compendium review examines the full spectrum of exercise-induced cardiac remodeling. We begin by tracing the historical context of how the athlete’s heart was discovered and progressively understood. We then explore the morphological and functional adaptations that arise with different exercise modalities, distinguishing between endurance and resistance training effects. The review further investigates the molecular and genetic underpinnings of exercise-induced cardiac remodeling, leveraging data from both human subjects and experimental animal models. We also address the clinical challenges posed by exercise-induced cardiac remodeling, including its phenotypic overlap with cardiomyopathies, such as hypertrophic, dilated, and arrhythmogenic right ventricular cardiomyopathy. These overlaps complicate athlete evaluation and risk stratification, particularly in preparticipation screening and return-to-play decisions. Finally, we explore concerns regarding the long-term effects of high-volume endurance training, including potential maladaptation. Together, this review offers a synthesis of current knowledge and a window into the athlete’s heart. By integrating perspectives from history, physiology, molecular biology, and clinical cardiology, we aim to highlight the distinctiveness of this phenotype and why it warrants focused scientific inquiry.

Year:

2025

Year:

2025

Aims The shift in mitral stenosis (MS) aetiology from rheumatic to calcific valve disease complicates distinguishing valve-related from myocardial-driven haemodynamic abnormalities. This study examines how left-heart myopathy influences flow velocity-based echocardiographic MS severity assessment and evaluates haemodynamic changes following mitral valve (MV) intervention at rest and during exercise. Methods and results The CircAdapt biophysical model was used to create a virtual cohort with varying MS severity, left ventricular (LV) compliance, and left atrial (LA) function. Mean gradient (MG) was evaluated alongside left-heart pressures at rest and during exercise. To study acute haemodynamic effects of MV intervention, the mitral valve’s effective orifice area was restored to 5.9 cm². MG showed variation of 1 mmHg attributable to left-heart myopathy. Following virtual MV intervention for clinically significant MS, mean left atrial pressure (mLAP) decreased by 50% in patients with preserved myocardial function but remained elevated in those with LV and LA dysfunction due to persistently elevated LV end-diastolic pressure, resulting in persistently impaired exercise capacity. Conclusion Virtual patient cohorts suggest that MV intervention reduces MG but may not normalize mLAP in patients with impaired LV and LA function. Persistent myocardial dysfunction may limit both symptomatic and exercise capacity improvement, despite successful intervention. As percutaneous treatment options expand, distinguishing myocardial from valve-driven abnormalities is essential for accurate assessment, patient selection, and optimizing outcomes.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (18)

Kristina Haugaa

Professor

University of Oslo

NORWAY
View details

James Guseh

Massachusetts General Hospital

UNITED STATES
View details

Haobo Li

Assistant Professor

Harvard University

UNITED STATES
View details

Flavio D’Ascenzi

University of Siena

ITALY
View details

Mahnaz Maddah

Director, Machine Learning for Health

Broad Institute

UNITED STATES
View details

Thijs Eijsvogels

Associate Professor

Radboud University Medical Center

NETHERLANDS
View details

Gitte van den Acker

University of Maastricht

NETHERLANDS
View details

Joost Lumens

Professor at Maastricht University

University of Maastricht

NETHERLANDS
View details

Kristen Kucera

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Jonathan Drezner

Professor

University of Washington

UNITED STATES
View details

Aaron Baggish

Professor

University of Lausanne

SWITZERLAND
View details

Ada C. Stefanescu Schmidt

Harvard University

UNITED STATES
View details

Bradley Petek

Oregon Health & Science University

UNITED STATES
View details

James Pirruccello

University of California, San Francisco

UNITED STATES
View details

Elizabeth Dineen

Assistant Professor

Mayo Clinic Florida

UNITED STATES
View details

Luisa Mestroni

Professor of Medicine

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Kimberly Harmon

Professor

University of Washington

UNITED STATES
View details

Jonathan H. Kim

Sports Cardiology

Emory University

UNITED STATES
View details